Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities

Nara Sobreira, Martha Brucato, Li Zhang, Christine Marie Ladd-Acosta, Chrissie Ongaco, Jane Romm, Kimberly Doheny, Regina C. Mingroni-Netto, Debora Bertola, Chong A. Kim, Ana Ba Perez, Maria I. Melaragno, David Valle, Vera A. Meloni, Hans Tomas Bjornsson

Research output: Contribution to journalArticle

Abstract

Kabuki syndrome is a monogenic disorder caused by loss of function variants in either of two genes encoding histone-modifying enzymes. We performed targeted sequencing in a cohort of 27 probands with a clinical diagnosis of Kabuki syndrome. Of these, 12 had causative variants in the two known Kabuki syndrome genes. In 2, we identified presumptive loss of function de novo variants in KMT2A (missense and splice site variants), a gene that encodes another histone modifying enzyme previously exclusively associated with Wiedermann-Steiner syndrome. Although Kabuki syndrome is a disorder of histone modification, we also find alterations in DNA methylation among individuals with a Kabuki syndrome diagnosis relative to matched normal controls, regardless of whether they carry a variant in KMT2A or KMT2D or not. Furthermore, we observed characteristic global abnormalities of DNA methylation that distinguished patients with a loss of function variant in KMT2D or missense or splice site variants in either KMT2D or KMT2A from normal controls. Our results provide new insights into the relationship of genotype to epigenotype and phenotype and indicate cross-talk between histone and DNA methylation machineries exposed by inborn errors of the epigenetic apparatus.

Original languageEnglish (US)
Pages (from-to)1335-1344
Number of pages10
JournalEuropean Journal of Human Genetics
Volume25
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

DNA Methylation
Phenotype
Histones
Histone Code
Genes
Enzymes
Epigenomics
Genotype
Kabuki syndrome

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities. / Sobreira, Nara; Brucato, Martha; Zhang, Li; Ladd-Acosta, Christine Marie; Ongaco, Chrissie; Romm, Jane; Doheny, Kimberly; Mingroni-Netto, Regina C.; Bertola, Debora; Kim, Chong A.; Perez, Ana Ba; Melaragno, Maria I.; Valle, David; Meloni, Vera A.; Bjornsson, Hans Tomas.

In: European Journal of Human Genetics, Vol. 25, No. 12, 01.12.2017, p. 1335-1344.

Research output: Contribution to journalArticle

Sobreira, N, Brucato, M, Zhang, L, Ladd-Acosta, CM, Ongaco, C, Romm, J, Doheny, K, Mingroni-Netto, RC, Bertola, D, Kim, CA, Perez, AB, Melaragno, MI, Valle, D, Meloni, VA & Bjornsson, HT 2017, 'Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities', European Journal of Human Genetics, vol. 25, no. 12, pp. 1335-1344. https://doi.org/10.1038/s41431-017-0023-0
Sobreira, Nara ; Brucato, Martha ; Zhang, Li ; Ladd-Acosta, Christine Marie ; Ongaco, Chrissie ; Romm, Jane ; Doheny, Kimberly ; Mingroni-Netto, Regina C. ; Bertola, Debora ; Kim, Chong A. ; Perez, Ana Ba ; Melaragno, Maria I. ; Valle, David ; Meloni, Vera A. ; Bjornsson, Hans Tomas. / Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities. In: European Journal of Human Genetics. 2017 ; Vol. 25, No. 12. pp. 1335-1344.
@article{28f638dd29774eb4895568f476524670,
title = "Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities",
abstract = "Kabuki syndrome is a monogenic disorder caused by loss of function variants in either of two genes encoding histone-modifying enzymes. We performed targeted sequencing in a cohort of 27 probands with a clinical diagnosis of Kabuki syndrome. Of these, 12 had causative variants in the two known Kabuki syndrome genes. In 2, we identified presumptive loss of function de novo variants in KMT2A (missense and splice site variants), a gene that encodes another histone modifying enzyme previously exclusively associated with Wiedermann-Steiner syndrome. Although Kabuki syndrome is a disorder of histone modification, we also find alterations in DNA methylation among individuals with a Kabuki syndrome diagnosis relative to matched normal controls, regardless of whether they carry a variant in KMT2A or KMT2D or not. Furthermore, we observed characteristic global abnormalities of DNA methylation that distinguished patients with a loss of function variant in KMT2D or missense or splice site variants in either KMT2D or KMT2A from normal controls. Our results provide new insights into the relationship of genotype to epigenotype and phenotype and indicate cross-talk between histone and DNA methylation machineries exposed by inborn errors of the epigenetic apparatus.",
author = "Nara Sobreira and Martha Brucato and Li Zhang and Ladd-Acosta, {Christine Marie} and Chrissie Ongaco and Jane Romm and Kimberly Doheny and Mingroni-Netto, {Regina C.} and Debora Bertola and Kim, {Chong A.} and Perez, {Ana Ba} and Melaragno, {Maria I.} and David Valle and Meloni, {Vera A.} and Bjornsson, {Hans Tomas}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41431-017-0023-0",
language = "English (US)",
volume = "25",
pages = "1335--1344",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities

AU - Sobreira, Nara

AU - Brucato, Martha

AU - Zhang, Li

AU - Ladd-Acosta, Christine Marie

AU - Ongaco, Chrissie

AU - Romm, Jane

AU - Doheny, Kimberly

AU - Mingroni-Netto, Regina C.

AU - Bertola, Debora

AU - Kim, Chong A.

AU - Perez, Ana Ba

AU - Melaragno, Maria I.

AU - Valle, David

AU - Meloni, Vera A.

AU - Bjornsson, Hans Tomas

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Kabuki syndrome is a monogenic disorder caused by loss of function variants in either of two genes encoding histone-modifying enzymes. We performed targeted sequencing in a cohort of 27 probands with a clinical diagnosis of Kabuki syndrome. Of these, 12 had causative variants in the two known Kabuki syndrome genes. In 2, we identified presumptive loss of function de novo variants in KMT2A (missense and splice site variants), a gene that encodes another histone modifying enzyme previously exclusively associated with Wiedermann-Steiner syndrome. Although Kabuki syndrome is a disorder of histone modification, we also find alterations in DNA methylation among individuals with a Kabuki syndrome diagnosis relative to matched normal controls, regardless of whether they carry a variant in KMT2A or KMT2D or not. Furthermore, we observed characteristic global abnormalities of DNA methylation that distinguished patients with a loss of function variant in KMT2D or missense or splice site variants in either KMT2D or KMT2A from normal controls. Our results provide new insights into the relationship of genotype to epigenotype and phenotype and indicate cross-talk between histone and DNA methylation machineries exposed by inborn errors of the epigenetic apparatus.

AB - Kabuki syndrome is a monogenic disorder caused by loss of function variants in either of two genes encoding histone-modifying enzymes. We performed targeted sequencing in a cohort of 27 probands with a clinical diagnosis of Kabuki syndrome. Of these, 12 had causative variants in the two known Kabuki syndrome genes. In 2, we identified presumptive loss of function de novo variants in KMT2A (missense and splice site variants), a gene that encodes another histone modifying enzyme previously exclusively associated with Wiedermann-Steiner syndrome. Although Kabuki syndrome is a disorder of histone modification, we also find alterations in DNA methylation among individuals with a Kabuki syndrome diagnosis relative to matched normal controls, regardless of whether they carry a variant in KMT2A or KMT2D or not. Furthermore, we observed characteristic global abnormalities of DNA methylation that distinguished patients with a loss of function variant in KMT2D or missense or splice site variants in either KMT2D or KMT2A from normal controls. Our results provide new insights into the relationship of genotype to epigenotype and phenotype and indicate cross-talk between histone and DNA methylation machineries exposed by inborn errors of the epigenetic apparatus.

UR - http://www.scopus.com/inward/record.url?scp=85038590754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038590754&partnerID=8YFLogxK

U2 - 10.1038/s41431-017-0023-0

DO - 10.1038/s41431-017-0023-0

M3 - Article

C2 - 29255178

AN - SCOPUS:85038590754

VL - 25

SP - 1335

EP - 1344

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

IS - 12

ER -